This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Top Healthcare Picks: Kura Oncology (KURA), Align Tech (ALGN)

Tipranks - Tipranks - Fri Jun 5, 3:56AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kura Oncology (KURA) and Align Tech (ALGN) with bullish sentiments.

Claim 55% Off TipRanks

Kura Oncology (KURA)

In a report released today, Etzer Darout from Barclays maintained a Buy rating on Kura Oncology, with a price target of $28.00. The company’s shares closed last Wednesday at $8.66, close to its 52-week low of $6.79.

According to TipRanks.com, Darout is a 5-star analyst with an average return of 23.1% and a 51.2% success rate. Darout covers the Healthcare sector, focusing on stocks such as First Tracks Biotherapeutics Inc, Protagonist Therapeutics, and Monopar Therapeutics Inc. ;'>

Currently, the analyst consensus on Kura Oncology is a Strong Buy with an average price target of $28.11, a 214.1% upside from current levels. In a report issued on May 21, Bank of America Securities also maintained a Buy rating on the stock with a $30.00 price target.

See today’s best-performing stocks on TipRanks >>

Align Tech (ALGN)

Barclays analyst Glen Santangelo maintained a Buy rating on Align Tech today and set a price target of $200.00. The company’s shares closed last Wednesday at $161.71, close to its 52-week low of $157.57.

According to TipRanks.com, Santangelo is a 3-star analyst with an average return of 2.9% and a 50.2% success rate. Santangelo covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, Amphastar Pharmaceuticals, and Bausch Health Companies. ;'>

Align Tech has an analyst consensus of Moderate Buy, with a price target consensus of $208.00, which is a 25.1% upside from current levels. In a report issued on May 20, TipRanks – Google also upgraded the stock to Buy with a $178.00 price target.

Read More on KURA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).